Static vs. Dynamic Progressive Splinting for Persistent Wrist Stiffness After DRF
A Two-Arm, Parallel-Group Randomized Controlled Trial Comparing Static Progressive Splinting Versus Dynamic Splinting for Improving Wrist PROM/AROM in Patients With Persistent Post-DRF Stiffness
1 other identifier
interventional
50
1 country
1
Brief Summary
This randomized controlled trial will compare the effectiveness of static progressive splinting versus dynamic splinting for treating persistent wrist stiffness in adults ≥18 years old at least 8 weeks post distal radius fracture (DRF) injury. Both splinting modalities are provided as an adjunct to one weekly supervised therapy session over a 6-week period. The primary outcomes are wrist active and passive range of motion (AROM/PROM) measured using goniometry, with secondary outcomes including patient-reported wrist function (PRWE), overall satisfaction, and adverse events.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 31, 2025
CompletedFirst Posted
Study publicly available on registry
April 6, 2025
CompletedStudy Start
First participant enrolled
April 17, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 17, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
April 17, 2026
CompletedApril 6, 2025
March 1, 2025
1 year
March 31, 2025
March 31, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Wrist Active and Passive Range of Motion (AROM/PROM)
Measured using a standard goniometer, improvements in wrist flexion and extension (in degrees) are the primary indicators of treatment efficacy.
Assessed at baseline, 6 weeks (post-intervention), and 3 months follow-up.
Secondary Outcomes (3)
Patient-Rated Wrist Evaluation (PRWE)
Assessed at baseline and at 6 weeks post-intervention.
Patient Satisfaction
Collected at 6 weeks and 3 months post-intervention.
Incidence of Adverse Events
Continuously monitored from baseline to the 3-month follow-up.
Study Arms (2)
Static Progressive Splinting Group (SPSG)
EXPERIMENTALParticipants in this group receive static progressive splinting using a commercial splint that allows incremental adjustment through a turnbuckle design. This splint is used to gradually increase wrist extension and/or flexion, tailored to the patient's stiffness pattern, alongside a once-weekly supervised therapy session.
Dynamic Splinting Group (DSG)
EXPERIMENTALParticipants in this group receive dynamic splinting using a commercial device equipped with elastic tension (spring-loaded) that provides a constant dynamic stretch to the wrist. This intervention is delivered alongside a weekly supervised therapy session.
Interventions
A commercially available static progressive splint with a turnbuckle mechanism allowing fine-tuned adjustments in wrist flexion and extension. Instructional materials for home use including written guidelines and an adjustment log.
Materials: A commercially available dynamic (spring-loaded) splint designed for the wrist. An instructional manual and daily usage log for participants.
Eligibility Criteria
You may qualify if:
- Adults aged 18 years or older. At least 8 weeks post distal radius fracture (operative or nonoperative) who have completed standard rehabilitation.
- Demonstrated persistent wrist stiffness with ≤50% of contralateral wrist extension or flexion.
- Capable of providing written informed consent and complying with study procedures
You may not qualify if:
- Presence of complex regional pain syndrome (CRPS) or active fracture healing issues.
- History of significant wrist pathology unrelated to the DRF. Uncontrolled medical conditions that would interfere with splint application or therapy.
- Known skin conditions or allergies that preclude orthosis use. Inability or unwillingness to adhere to the intervention protocol or follow-up schedule.
- Pregnant or breastfeeding individuals.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Faculty of Physical Therapy, Al Hayah University
Cairo, 12311, Egypt
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 31, 2025
First Posted
April 6, 2025
Study Start
April 17, 2025
Primary Completion
April 17, 2026
Study Completion
April 17, 2026
Last Updated
April 6, 2025
Record last verified: 2025-03
Data Sharing
- IPD Sharing
- Will not share